Arkansas Foundation for Medical Care report: preventing stroke in atrial fibrillation

Area of Science:

• Gerontology
• Cardiology
• Neurology

Background:

• Atrial fibrillation is a prevalent condition in elderly populations.
• Atrial fibrillation significantly elevates stroke risk by fivefold compared to sinus rhythm.
• Warfarin demonstrates a two-thirds stroke risk reduction in this demographic, while aspirin offers a lesser benefit.

Purpose of the Study:

• To assess the utilization of warfarin and aspirin for stroke primary prophylaxis in elderly patients with atrial fibrillation.
• To identify factors influencing the prescription patterns of stroke prophylaxis in this patient group.

Main Methods:

• Retrospective analysis of patient data.
• Examination of statewide prescription patterns for warfarin and aspirin.
• Comparison of prophylaxis use based on hospital characteristics (size, location).

Main Results:

• Statewide, warfarin was used for primary prophylaxis in 21% of patients under 80 with atrial fibrillation.
• Overall use of either warfarin or aspirin for stroke prophylaxis reached 42%.
• Smaller hospitals and those outside Central Arkansas demonstrated lower rates of warfarin and any stroke prophylaxis use.

Conclusions:

• Warfarin is an effective stroke risk reduction therapy for elderly patients with atrial fibrillation.
• There are disparities in the utilization of stroke prophylaxis, with smaller and non-Central Arkansas hospitals prescribing it less frequently.
• Further research is needed to address the underutilization of evidence-based stroke prevention strategies in certain healthcare settings.